$36.34 -1.10 (%) Clovis Oncology Inc - NASDAQ

Sep. 28, 2016 | 04:00 PM

Partner Headlines

  1. Gilead Slips As Former Bull Turns Bearish On Hep C Business

    TalkMarkets | Sep. 27, 2016 | 15:10PM EST
  2. Benzinga's Top Initiations

    Benzinga | Dec. 17, 2015 | 10:02AM EST
  3. Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib

    Benzinga | Dec. 15, 2015 | 16:16PM EST
  4. Benzinga's M&A Chatter for Tuesday December 1, 2015

    Benzinga | Dec. 1, 2015 | 19:29PM EST
  5. Kyle Bass Builds Bull Case for Clovis Oncology

    GuruFocus | Nov. 27, 2015 | 09:14AM EST
  6. Clovis Oncology Continues Lower After Consolidation

    Benzinga | Nov. 23, 2015 | 13:06PM EST
  7. KaloBios, Valeant Lead Week's 5 Top Drug Stock Gainers

    IBD | Nov. 21, 2015 | 08:15AM EST
  8. Morning Market Losers

    Benzinga | Nov. 17, 2015 | 09:56AM EST
  9. Benzinga's Top Downgrades

    Benzinga | Nov. 17, 2015 | 09:26AM EST
  10. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 17, 2015 | 08:18AM EST
  11. Biotech Clovis Oncology

    IBD | Nov. 16, 2015 | 18:41PM EST
  12. Mid-Afternoon Market Update: Dow Surges More Than 200 Points; Dillard's Shares Dip On Earnings Miss

    Benzinga | Nov. 16, 2015 | 15:12PM EST
  13. Mid-Day Market Update: Starwood Drops Following Announcement of Acquisition Deal With Marriott; Sunoco Shares Gain

    Benzinga | Nov. 16, 2015 | 12:16PM EST
  14. Clovis Stumbles, AstraZeneca Leads Cancer Drug Race

    IBD | Nov. 16, 2015 | 11:03AM EST
  15. What The FDA Gave Clovis Oncology In June 2013, It Has Taken Away

    Benzinga | Nov. 16, 2015 | 10:45AM EST
  16. Mid-Morning Market Update: Markets Edge Higher; Marriott To Acquire Starwood Hotels For $12.2B

    Benzinga | Nov. 16, 2015 | 10:09AM EST
  17. Morning Market Losers

    Benzinga | Nov. 16, 2015 | 09:58AM EST
  18. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD | Oct. 5, 2015 | 08:02AM EST
  19. Clovis Oncology Announces U.S. and E.U. Regulatory Milestones for Rociletinib in the Treatment of Advanced EGFR-Mutant T790M+ Non-Small Cell Lung Cancer

    Benzinga | Sep. 29, 2015 | 16:01PM EST
  20. Clovis Oncology Announces Data Presentations at 16th World Conference on Lung Cancer September 6-9, 2015

    Benzinga | Sep. 4, 2015 | 06:03AM EST
  21. Clovis Oncology Completes US, EU Regulatory Submissions for Rociletinib for Treatment of Advanced EGFR-Mutant T790M+ NSCLC

    Benzinga | Aug. 3, 2015 | 06:03AM EST
  22. Benzinga's Top Upgrades

    Benzinga | Jul. 20, 2015 | 09:14AM EST
  23. Clovis Oncology Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

    Benzinga | Jul. 10, 2015 | 06:01AM EST
  24. Clovis Oncology Initiates Rolling NDA Submission to the FDA for Rociletinib in the Treatment of Advanced EGFR-Mutant Non-small Cell Lung Cancer

    Benzinga | Jul. 1, 2015 | 16:06PM EST
  25. Morning Market Losers

    Benzinga | Jun. 1, 2015 | 10:25AM EST
  26. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus | Apr. 14, 2015 | 21:01PM EST
  27. Clovis Technology Gets Big Boost From Goldman Upgrade

    IBD | Apr. 13, 2015 | 16:06PM EST
  28. Benzinga's Volume Movers

    Benzinga | Apr. 13, 2015 | 10:25AM EST
  29. Morning Market Gainers

    Benzinga | Apr. 13, 2015 | 09:41AM EST
  30. Benzinga's Top Upgrades

    Benzinga | Apr. 13, 2015 | 09:08AM EST
  31. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 13, 2015 | 08:12AM EST
  32. Goldman Sachs Upgrades Clovis Oncology To Buy

    Benzinga | Apr. 13, 2015 | 07:45AM EST
  33. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  34. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  35. Morning Market Losers

    Benzinga | Nov. 19, 2014 | 09:53AM EST
  36. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration With GlaxoSmithKline

    Benzinga | Nov. 17, 2014 | 17:00PM EST
  37. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga | Nov. 7, 2014 | 08:33AM EST
  38. Morning Market Losers

    Benzinga | Sep. 3, 2014 | 09:50AM EST
  39. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga | Jul. 18, 2014 | 15:40PM EST
  40. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga | Jun. 23, 2014 | 07:41AM EST
  41. Market Wrap For June 5: Markets Positive Before Friday's Employment Report

    Benzinga | Jun. 5, 2014 | 16:35PM EST
  42. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga | Jun. 5, 2014 | 10:38AM EST
  43. Market Wrap For June 4: Markets Slightly Higher On Light Volume, Beige Book

    Benzinga | Jun. 4, 2014 | 16:38PM EST
  44. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga | Jun. 4, 2014 | 08:32AM EST
  45. Benzinga's Volume Movers

    Benzinga | Mar. 27, 2014 | 10:34AM EST
  46. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 27, 2014 | 08:20AM EST
  47. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive Phase 1 Trial Results for NSCLC Treatment

    Benzinga | Mar. 27, 2014 | 07:54AM EST
  48. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga | Mar. 27, 2014 | 07:33AM EST
  49. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues Downbeat Q1 Forecast

    Benzinga | Mar. 26, 2014 | 10:24AM EST
  50. Benzinga's Top Initiations

    Benzinga | Mar. 24, 2014 | 08:21AM EST
Trading Center